Merck Locks Infinimmune Alliance To Chase Next-Gen Antibody Drugs

All NewsApril 1, 2026

Infinimmune, Merck ink deal to develop human-derived antibodies using the Anthrobody platform. See the full agreement details.

Importance Rank:

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent